Status:

COMPLETED

Nerve Growth Factor in Chronic Pancreatitis

Lead Sponsor:

Virginia Commonwealth University

Collaborating Sponsors:

Stanford University

Conditions:

Chronic Pancreatitis

Eligibility:

All Genders

18-70 years

Brief Summary

This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis. Hypothesis: 1. Pain does not correlate with change...

Eligibility Criteria

Inclusion

  • Patients with established CP and none of the exclusion criteria mention below.

Exclusion

  • Failure to obtain consent.
  • Any comorbid condition with expected survival \< 1 year.
  • Patients with pacemaker, implanted metallic prosthesis or other contraindications to do MRCP.
  • Patients \< 18 years of age at time of consent

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT01255917

Start Date

February 1 2008

End Date

August 1 2011

Last Update

March 7 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Virginia Commonwealth University Medical Center

Richmond, Virginia, United States, 23298